Introduction Calciprotein particles (CPPs) are potentially modifiable mediators of phosphate
toxicity in patients with kidney disease. We compared the effects of calcium carbonate (CC) …

Patients with chronic kidney disease (CKD) have an extremely poor cardiovascular
outcome. Arterial stiffness, a strong independent predictor of survival in CKD, is connected to …

Background and aim Vascular calcification is an independent risk factor for cardiovascular
diseases and all-cause mortality in end stage renal disease, and particularly in hemodialysis …

The changes in phosphate (PO4) metabolism across the spectrum of chronic kidney disease
(CKD) and specific strategies to address these abnormalities by reducing PO4 loads are …

Background: Increased carotid-femoral pulse wave velocity (cf-PWV), a surrogate of
increased aortic stiffness, is a risk factor for cardiovascular events and all-cause mortality in …

Increased arterial stiffness is a marker of vasculopathy in chronic kidney disease (CKD)
patients, suggesting a significant cardiovascular damage. Detection of arterial stiffness …

Background High concentrations of both phosphate and fibroblast growth factor 23 (FGF23)
observed in chronic kidney disease (CKD) are associated with an increased risk of …

Background Vitamin D deficiency is common in peritoneal dialysis (PD) patients, so its
supplementation has been advocated as potentially beneficial. Methods Double-blind …

Sevelamer is a calcium‐free and metal‐free phosphate‐binding oral drug used in the
management of hyperphosphataemia in chronic kidney disease. Preclinical and clinical …

Increased aortic stiffness is an independent predictor of death from cardiovascular disease
in patients with end-stage renal disease (ESRD). Various factors that contribute to carotid …